0001209191-15-047677.txt : 20150528
0001209191-15-047677.hdr.sgml : 20150528
20150528183512
ACCESSION NUMBER: 0001209191-15-047677
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150526
FILED AS OF DATE: 20150528
DATE AS OF CHANGE: 20150528
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: PHARMACYCLICS INC
CENTRAL INDEX KEY: 0000949699
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 943148201
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: PHARMACYCLICS INC
STREET 2: 995 E ARQUES AVE
CITY: SUNNYVALE
STATE: CA
ZIP: 94085-4521
BUSINESS PHONE: 408 774 0330
MAIL ADDRESS:
STREET 1: PHARMACYCLICS INC
STREET 2: 995 E ARQUES AVE
CITY: SUNNYVALE
STATE: CA
ZIP: 94085-4521
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Soni Manmeet Singh
CENTRAL INDEX KEY: 0001569769
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-26658
FILM NUMBER: 15896736
MAIL ADDRESS:
STREET 1: C/O PHARMACYCLICS, INC.
STREET 2: 995 EAST ARQUES AVE
CITY: SUNNYVALE
STATE: CA
ZIP: 94085
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2015-05-26
0
0000949699
PHARMACYCLICS INC
PCYC
0001569769
Soni Manmeet Singh
C/O PHARMACYCLICS, INC.
995 EAST ARQUES AVE
SUNNYVALE
CA
94085
0
1
0
0
Chief Financial Officer
Common Stock
2015-05-26
4
D
0
54000
261.25
D
873
D
Common Stock
2015-05-26
4
U
0
873
261.25
D
0
D
Common Stock (Right to Buy)
61.60
2015-05-26
4
D
0
11152
D
2022-10-26
Common Stock
11152
0
D
Common Stock (Right to Buy)
70.37
2015-05-26
4
D
0
18750
D
2023-02-12
Common Stock
18750
0
D
Common Stock (Right to Buy)
106.75
2015-05-26
4
D
0
15000
D
2023-08-16
Common Stock
15000
0
D
Common Stock (Right to Buy)
138.66
2015-05-26
4
D
0
8000
D
2024-02-28
Common Stock
8000
0
D
Common Stock (Right to Buy)
102.22
2015-05-26
4
D
0
40000
D
2024-04-02
Common Stock
4000
0
D
Represents shares issuable pursuant to a Restricted Stock Unit Award that was cancelled in exchange for a cash payment, subject to applicable withholding taxes and pursuant to the procedures terms set forth in the Agreement and Plan of Reorganization (the "Merger Agreement") dated March 4, 2015, by and between the Issuer, AbbVie Inc., a Delaware corporation ("AbbVie"), Oxford Amherst Corporation, a Delaware corporation and a direct wholly owned subsidiary of AbbVie and Oxford Amherst LLC, a Delaware limited liability company and a direct wholly owned subsidiary of AbbVie.
Includes 262 shares acquired under the Pharmacyclics, Inc. Employee Stock Purchase Plan on April 30, 2015.
Price reflects aggregate per share consideration paid pursuant to the Tender Offer.
This option was cancelled pursuant to the terms of the Merger Agreement in exchange for a cash payment equal to the number of shares subject to the option multiplied by the difference between $261.25 and the exercise price of the option, subject to applicable withholding taxes and pursuant to the procedures set forth in the Merger Agreement.
/s/ Manmeet S. Soni
2015-05-27